Article
ASXL1/TET2 genotype-based risk stratification outperforms ASXL1 mutational impact and is independent of mutant variant allele fractions in chronic myelomonocytic leukemia.
Haematologica - 1 Oct 2024
Csizmar Clifford M, Gurney Mark, Kanagal-Shamanna Rashmi, Chien Kelly, Hammond Danielle, Lasho Terra L, Finke Christy M, Dean Christopher, Natu Anuya, Mangaonkar Abhishek A, Al-Kali Aref, Gangat Naseema, Tefferi Ayalew, Alkhateeb Hassan, Garcia-Manero Guillermo, Komrokji Rami S, Ali Najla A, Padron Eric, Montalban-Bravo Guillermo, Patnaik Mrinal M
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.